This market research report presents a detailed segmentation of the global acne drugs market by drug class (antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid), by route of administration (topical, and oral), and by type (prescription and OTC). It outlines the market shares for key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Allergan, Galderma, Stiefel, and Valeant.
Technavio has released its new market research report, global acne drugs market, which is expected to grow at a CAGR of around 3% between 2016 and 2020. Increase in dermatological consultation for acne treatment options is boosting this market’s growth. The US is a major revenue contributor to the global market for acne drugs, occupying around 90% of the overall revenue share. Increase in the use of prescription drugs has led to the surge in revenue of acne drugs in this region.
“People are opting for combination therapies for acne treatment as these are safer and more effective than monotherapies. For instance, the sales of combination products such as Duac and Ziana is expected to increase during the forecast period. Physicians are also prescribing a combination of topical and oral formulations for faster and effective treatment for acne. Moreover, the manufacturers are also developing organic products that are free from toxins or parabens,” says Imran Mushtaq, Lead Analyst, Healthcare & Lifesciences, Technavio Research.
Topical medications dominate the market for acne treatment, accounting for around 54% of the overall market revenue. These are available as creams, gels, ointments, patches, and lotions, and are applied to the skin or mucous membrane. These are preferred over oral formulations as they contain antibiotics that destroy the bacterial cells present on skin. Epiduo is the most widely used topical prescription drugs.
The leading vendors in the global acne drugs market include Allergan, Galderma, Stiefel Laboratories, and Valeant Pharmaceuticals. Though the market is dominated by few major players, it presents significant opportunities for other vendors. Companies such as Cosmo Pharmaceuticals, Dermira, and Paratek Pharmaceuticals are expectred to enter this market during the forecast period.
A more detailed analysis is available in the Technavio report, Global Acne Drugs Market 2016-2020.
We can customize this reports by other regions and specific segments upon request.
Other Related Reports:
